Holen Sie sich die Stockscreener-App
5.86
3.14%
-0.19
Terns Pharmaceuticals Inc Aktie (TERN) Neueste Nachrichten
Terns Pharmaceuticals (NASDAQ:TERN) Trading Down 4.7%Should You Sell? - MarketBeat
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Shares Bought by Charles Schwab Investment Management Inc. - Defense World
Terns Pharmaceuticals' SWOT analysis: promising pipeline drives stock potential - Investing.com
Is Terns Pharmaceuticals, Inc. (TERN) the Best Weight Loss Stock to Buy Now According to Hedge Funds? - Insider Monkey
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Stake Reduced by Fmr LLC - MarketBeat
Insider Spends US$110k Buying More Shares In Terns Pharmaceuticals - Simply Wall St
Terns Pharmaceuticals CEO & Director Acquires 423% More Stock - Yahoo Finance
Terns Pharmaceuticals (NASDAQ:TERN) Shares Gap Up Following Insider Buying Activity - Defense World
Terns pharmaceuticals CEO Amy Burroughs acquires $110,467 in stock - Investing.com India
Terns pharmaceuticals CEO Amy Burroughs acquires $110,467 in stock By Investing.com - Investing.com Canada
17,369 Shares in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Bought by Intech Investment Management LLC - Defense World
Terns Pharmaceuticals' SWOT analysis: stock poised for growth amid clinical milestones By Investing.com - Investing.com South Africa
Terns Pharmaceuticals' SWOT analysis: stock poised for growth amid clinical milestones - Investing.com
Terns Pharma broadens beyond obesity drugs with upbeat data in leukemia trial - MSN
Walleye Capital LLC Takes $1.55 Million Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat
Terns’s stock soars as analysts cheer leukemia data — and predict more gains - MSN
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Shares Acquired by Parkman Healthcare Partners LLC - MarketBeat
Cinctive Capital Management LP Buys Shares of 168,564 Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat
Terns reports positive early results in CML drug trial By Investing.com - Investing.com Nigeria
U.S. STOCKS BlackRock, Terns Pharma, PSQ Holdings - XM
Terns Pharmaceuticals Reports Inducement Grant to New Employee under Nasdaq Listing Rule 5635(4) - Marketscreener.com
Terns reports positive early results in CML drug trial - Investing.com
Terns Pharmaceuticals Announces Positive Early Data from - GlobeNewswire
Terns Pharma's CML Drug Shows 50% Response Rate in Phase 1 Trial, Strong Safety Profile - StockTitan
Terns Pharmaceuticals Announces Positive Early Data from Phase 1 CARDINAL Trial of TERN-701 for Chronic Myeloid Leukemia - The Manila Times
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Quantbot Technologies LP Has $1.01 Million Stock Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat
Comparing Enliven Therapeutics (NASDAQ:ELVN) & Terns Pharmaceuticals (NASDAQ:TERN) - Defense World
Bellevue Group AG Takes $8.69 Million Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat
Acuta Capital Partners LLC Boosts Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat
Analysts Set Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Price Target at $27.25 - Defense World
Terns Pharmaceuticals (TERN) Stock Surges Over 5% Amid Biotech S - GuruFocus.com
Companies To Watch: Terns Pharmaceuticals - Life Science Leader Magazine
Terns Pharmaceuticals' SWOT analysis: stock poised for key data readouts By Investing.com - Investing.com Canada
Terns Pharmaceuticals' SWOT analysis: stock poised for key data readouts - Investing.com
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Telemark Asset Management LLC Acquires Shares of 300,000 Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat
Non-alcoholic Steatohepatitis (NASH) Treatment Market 2032: Clinical Trials, Medication, EMA, PDMA, FDA Approvals, Epidemiology, Therapies, Companies by DelveInsight - The Globe and Mail
104,535 Shares in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Purchased by Quest Partners LLC - MarketBeat
Terns Pharmaceuticals (TERN) Stock Drops Over 5% Amidst Mixed In - GuruFocus.com
Top 3 Health Care Stocks You'll Regret Missing In Q4Amarin Corp (NASDAQ:AMRN) - Benzinga
Terns Pharmaceuticals appoints new board member - Investing.com
Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors - GlobeNewswire
Terns Pharmaceuticals, Inc. Announces Board Changes - Marketscreener.com
Terns Pharmaceuticals Inc (TERN) Stock Price & Chart | Trade Now - Capital.com
Terns Pharmaceuticals (NASDAQ:TERN) Stock Price Down 8.7%Should You Sell? - MarketBeat
Steven Cohen's Strategic Acquisition in Terns Pharmaceuticals Inc - GuruFocus.com
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):